Ureteral cancer

Typical presentation

Symptoms are variable and may be subtle. Common complaints that prompt investigation include visible or microscopic blood in the urine and flank pain from obstruction. Some patients present after imaging for unrelated problems detects a lesion. Clinical features that raise suspicion include:

• Hematuria (blood in the urine)
• Flank or abdominal pain from urinary blockage
• Recurrent urinary tract infections or unexplained weight loss in advanced cases

Diagnosis and staging

Diagnosis relies on a combination of imaging, endoscopic inspection and tissue sampling. Cross-sectional imaging such as CT urography is commonly used to visualize the upper urinary tract. Direct visualization with ureteroscopy allows biopsy for histologic confirmation. Urine cytology and specialized urine tests may support the diagnosis but are less sensitive for upper tract tumors. Staging follows common cancer staging principles and guides treatment choices.

Treatment approaches

Management depends on tumor grade, stage, location and patient factors. Options include:

• Surgical resection: radical nephroureterectomy with bladder cuff excision is a standard for high-grade or invasive disease.
• Kidney-sparing techniques: segmental ureterectomy or endoscopic resection/ablation for selected low-grade, low-volume tumors.
• Systemic therapy: chemotherapy is used for advanced or metastatic disease; radiation may have a role in select situations.

Decisions are individualized and often made by a multidisciplinary team including urology, medical oncology and radiology.

Risk factors, epidemiology and prognosis

Ureteral cancer is rare compared with lower urinary tract cancer. It is more frequent in older adults. Known associations include tobacco smoking and exposures to certain industrial chemicals; hereditary conditions that predispose to upper urinary tract urothelial cancer have also been described. Prognosis varies widely: early, localized tumors treated with complete resection can have favorable outcomes, while invasive or metastatic disease carries a poorer prognosis. Long-term surveillance is important because of risks of recurrence in the bladder or contralateral upper tract.

Distinctions and further information

Ureteral tumors share histologic features with bladder urothelial cancer but differ in presentation, accessibility for biopsy and surgical management. Follow-up typically includes periodic imaging and cystoscopic evaluation of the bladder because of the risk of subsequent tumors. For patient-oriented resources and clinical guidelines see general reference and specialty resources at kidney-related sites or urinary health. Additional clinical research and guideline summaries can be found through professional organizations and designated registries here.